McLean Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Sell |
6,261
-218
| -3% | -$15.5K | 0.12% | 88 |
|
|
2025
Q1 | $420K | Buy |
6,479
+115
| +2% | +$7.46K | 0.14% | 84 |
|
|
2024
Q4 | $417K | Sell |
6,364
-144
| -2% | -$9.44K | 0.13% | 87 |
|
|
2024
Q3 | $504K | Sell |
6,508
-42
| -0.6% | -$3.25K | 0.15% | 76 |
|
|
2024
Q2 | $509K | Buy |
6,550
+319
| +5% | +$24.8K | 0.16% | 74 |
|
|
2024
Q1 | $426K | Hold |
6,231
| – | – | 0.15% | 82 |
|
|
2023
Q4 | $426K | Sell |
6,231
-34
| -0.5% | -$2.33K | 0.16% | 74 |
|
|
2023
Q3 | $426K | Hold |
6,265
| – | – | 0.17% | 68 |
|
|
2023
Q2 | $448K | Hold |
6,265
| – | – | 0.18% | 67 |
|
|
2023
Q1 | $435K | Hold |
6,265
| – | – | 0.18% | 68 |
|
|
2022
Q4 | $425K | Hold |
6,265
| – | – | 0.14% | 72 |
|
|
2022
Q3 | $347K | Buy |
6,265
+535
| +9% | +$29.6K | 0.13% | 80 |
|
|
2022
Q2 | $381K | Buy |
+5,730
| New | +$381K | 0.15% | 72 |
|